1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [6e532a0c-fe05-48e9-b674-cf4cbe1a3039] => Array
        (
            [runtime-id] => 6e532a0c-fe05-48e9-b674-cf4cbe1a3039
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [725f6afc-872a-45f5-b1d1-2b5d330c1b22] => Array
                        (
                            [runtime-id] => 725f6afc-872a-45f5-b1d1-2b5d330c1b22
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;538c814e61baaf80cbb9afc19ef11112dd76f7cc
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [6e532a0c-fe05-48e9-b674-cf4cbe1a3039] => Array
        (
            [runtime-id] => 6e532a0c-fe05-48e9-b674-cf4cbe1a3039
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [725f6afc-872a-45f5-b1d1-2b5d330c1b22] => Array
                        (
                            [runtime-id] => 725f6afc-872a-45f5-b1d1-2b5d330c1b22
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;538c814e61baaf80cbb9afc19ef11112dd76f7cc
                )

        )

)


Table 1: 
Patient characteristics
Characteristics
No.100
 Male60
 Female40
Age (mean) (yr)11.9 ± 5.5
Primary diagnosis (No.) (%)
 Hematologic malignancy65, 65%
  Acute myeloid leukemia34, 34%
  Acute lymphoblastic leukemia17, 17%
  Hodgkin lymphoma8, 8%
  Myelodysplastic syndrome5, 5%
  Anaplastic large-cell lymphoma1, 1%
 Hematologic disorder5, 5%
  Severe aplastic anemia3, 3%
  Sickle cell disease2, 2%
 Solid tumor28, 28%
  Neuroblastoma15, 15%
  Ewing sarcoma9, 9%
  Germ cell tumor3, 3%
  Desmoplastic small round cell tumor1, 1%
 Immune disorder2, 2%
  Severe combined immunodeficiency1. 1%
  Wiskott-Aldrich syndrome1, 1%
Transplant donor (No.) (%)
 Allogenic66, 66%
 Autologous34, 34%
Disease status at transplantation (No.) (%)
 Complete remission82, 82%
 Active disease18, 18%
T-cell depletion (No.) (%)2, 2%
GVHD II–IV (No.) (%)15, 15%